pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›HYDROCORTISONE
drug
save

HYDROCORTISONE

Preclinicalupdated 5mo ago
by $ETON Eton Pharmaceuticals, Inc.
Preclinical
community read0 votes

🐶 often sniffed alongside

top 8
  • drugNEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE16 co-mentions · 6 sources
  • tagApproval14 co-mentions · 5 sources
  • drugET-80012 co-mentions · 6 sources
  • drugpolymyxin B4 co-mentions · 2 sources
  • drugciprofloxacin2 co-mentions · 1 sources
  • drugCIPROFLOXACIN HYDROCHLORIDE2 co-mentions · 1 sources
  • drugciprofloxacin hydrochloride ER2 co-mentions · 1 sources
  • tagSmall Molecule1 co-mentions · 1 sources

all catalysts(0)

nothing on the calendar yet

Trials studying HYDROCORTISONE

  • phase1Comparison of Pharmacokinetics of Infacort® Versus Immediate-release Hydrocortisonecompletedn=16
  • phase2Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAHcompletedn=16
  • phase1An Investigational Study of Hydrocortisonecompletedn=14
  • phase3Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)recruitingn=1,310
  • phase2Lazarus: IT Therapy for ICANSnot yet recruitingn=59
  • phase3A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)recruitingn=1,314
  • phase1A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapyrecruitingn=36
  • phase1A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001)completedn=14

News(0)

no news has mentioned this drug yet

brand
HYDROCORTISONE
generic
HYDROCORTISONE
indication
Adrenal Insufficiency
phase
preclinical
Data sources
ClinicalTrials.gov
last refreshed 2h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?